Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.74B
Revenue (ttm)	567.06M
Net Income (ttm)	76.35M
Shares Out	44.93M
EPS (ttm)	1.68
PE Ratio	36.25
Forward PE	n/a
Dividend	1.75 (2.87%)
Ex-Dividend Date	Jun 26, 2025

Volume	31,818
Average Volume	18,590
Open	59.00
Previous Close	60.90
Day's Range	58.60 - 59.20
52-Week Range	56.60 - 88.30
Beta	-0.12
RSI	55.09
Earnings Date	Mar 30, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 199
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.